Investor Webinar | Unlocking Alzheimer’s Breakthroughs: Enabling better data-driven decisions to advance drug approvals As part of our investor webinar series, join us for an insightful conversation on the latest advancements in Alzheimer’s research and drug development. Tuesday 5 August at 9am AEST | Monday 4 August at 7pm US EST Featuring: · Akash Tewari, Equity Analyst, Jefferies · Brad O’Connor, CEO, Cogstate · Kaycee Sink, Chief Medical Officer, Cogstate · Rachel Colite, EVP Clinical Trials, Cogstate The panel will unpack key insights from AAIC 2025 and discuss: · Disease progression and treatment strategies · The evolving role of pharma in Alzheimer’s care · How Cogstate is supporting pre-symptomatic trials through better data Register now: https://lnkd.in/gDJwyvUu
